Graybug Vision, Inc. – NASDAQ:GRAY
Graybug Vision stock price monthly change
Graybug Vision stock price quarterly change
Graybug Vision stock price yearly change
Graybug Vision key metrics
Market Cap | 120.98M |
Enterprise value | N/A |
P/E | -0.26 |
EV/Sales | N/A |
EV/EBITDA | 0.47 |
Price/Sales | N/A |
Price/Book | 0.01 |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | -43.56M |
Income | N/A |
Revenue Q/Q | -100% |
Revenue Y/Y | 21.68% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGraybug Vision stock price history
Graybug Vision stock forecast
Graybug Vision financial statements
| Dec 2022 | 2.96M | -7.09M | -239.42% |
|---|---|---|---|
| Mar 2023 | 0 | -13.06M | |
| Jun 2023 | 0 | 0 | |
| Sep 2023 | 0 | 0 |
| 2023-05-08 | -0.45 | -15.87716 |
|---|
| Dec 2022 | 39670000 | 3.69M | 9.32% |
|---|---|---|---|
| Mar 2023 | 34669000 | 12.65M | 36.49% |
| Jun 2023 | 20245000 | 4.02M | 19.88% |
| Sep 2023 | 15845000 | 3.68M | 23.26% |
| Dec 2022 | -5.07M | 12.26M | -53K |
|---|---|---|---|
| Mar 2023 | -5.35M | 4.75M | 23.51M |
| Jun 2023 | 0 | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 |
Graybug Vision alternative data
| Aug 2023 | 8 |
|---|---|
| Sep 2023 | 8 |
| Oct 2023 | 8 |
| Nov 2023 | 8 |
| Dec 2023 | 8 |
| Jan 2024 | 8 |
| Feb 2024 | 8 |
| Mar 2024 | 8 |
| Apr 2024 | 8 |
| May 2024 | 8 |
| Jun 2024 | 8 |
| Jul 2024 | 8 |
Graybug Vision other data
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 45054 | 0 |
| Jun 2023 | 20314 | 0 |
| Aug 2023 | 3423 | 0 |
| Nov 2023 | 56900 | 0 |
| Patent |
|---|
Grant Filling date: 10 Sep 2019 Issue date: 17 May 2022 |
Grant Filling date: 10 May 2018 Issue date: 2 Nov 2021 |
Application Filling date: 13 May 2021 Issue date: 9 Sep 2021 |
Application Filling date: 25 Mar 2021 Issue date: 15 Jul 2021 |
Application Filling date: 22 Oct 2020 Issue date: 25 Mar 2021 |
Application Filling date: 22 Oct 2020 Issue date: 11 Feb 2021 |
Application Filling date: 11 Jun 2020 Issue date: 1 Oct 2020 |
Application Filling date: 17 Mar 2020 Issue date: 23 Jul 2020 |
Application Filling date: 20 Sep 2019 Issue date: 30 Jan 2020 |
Application Filling date: 10 Sep 2019 Issue date: 2 Jan 2020 |
| Insider | Compensation |
|---|---|
Dr. Frederic Guerard Pharm.D. (1972) Pres, Chief Executive Officer & Director | $873,620 |
| Dr. Parisa Zamiri M.D., Ph.D. (1965) Chief Medical Officer | $468,510 |
| Mr. Robert S. Breuil (1962) Chief Financial Officer | $441,080 |
| Dr. Gerald D. Cagle Ph.D. (1944) Senior Advisor, Head of Bus. Devel. & Director | $11,170 |
-
When is Graybug Vision's next earnings date?
Unfortunately, Graybug Vision's (GRAY) next earnings date is currently unknown.
-
Does Graybug Vision pay dividends?
No, Graybug Vision does not pay dividends.
-
How much money does Graybug Vision make?
Graybug Vision has a market capitalization of 120.98M. Graybug Vision made a loss 35.03M US dollars in net income (profit) last year or -$15.88 on an earnings per share basis.
-
What is Graybug Vision's stock symbol?
Graybug Vision, Inc. is traded on the NASDAQ under the ticker symbol "GRAY".
-
What is Graybug Vision's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Graybug Vision?
Shares of Graybug Vision can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Graybug Vision's key executives?
Graybug Vision's management team includes the following people:
- Dr. Frederic Guerard Pharm.D. Pres, Chief Executive Officer & Director(age: 53, pay: $873,620)
- Dr. Parisa Zamiri M.D., Ph.D. Chief Medical Officer(age: 60, pay: $468,510)
- Mr. Robert S. Breuil Chief Financial Officer(age: 63, pay: $441,080)
- Dr. Gerald D. Cagle Ph.D. Senior Advisor, Head of Bus. Devel. & Director(age: 81, pay: $11,170)
-
How many employees does Graybug Vision have?
As Jul 2024, Graybug Vision employs 8 workers.
-
When Graybug Vision went public?
Graybug Vision, Inc. is publicly traded company for more then 5 years since IPO on 4 Sep 2020.
-
What is Graybug Vision's official website?
The official website for Graybug Vision is graybug.vision.
-
Where are Graybug Vision's headquarters?
Graybug Vision is headquartered at 203 Redwood Shores Parkway, Redwood City, CA.
-
How can i contact Graybug Vision?
Graybug Vision's mailing address is 203 Redwood Shores Parkway, Redwood City, CA and company can be reached via phone at +65 04872800.
Graybug Vision company profile:
Graybug Vision, Inc.
graybug.visionNASDAQ
8
Biotechnology
Healthcare
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.
Redwood City, CA 94065
CIK: 0001534133
ISIN: US38942Q1031
CUSIP: 38942Q103
